[SCHEDULE 13G] NeoGenomics, Inc. SEC Filing

Rhea-AI Filing Summary

Three related reporting persons — Greenhouse Funds LLLP, Greenhouse GP LLC and Joseph Milano — each report beneficial ownership of 7,431,147 shares of NeoGenomics common stock, representing 5.8% of the class. The filing shows no sole voting or dispositive power and reports shared voting power of 6,658,116 and shared dispositive power of 7,431,147, indicating joint control over voting and disposition rather than individual control.

The statement explains these securities are directly owned by advisory clients of Greenhouse Funds LLLP, that the holdings were acquired and are held in the ordinary course of business and were not acquired to influence control of the issuer, and includes a disclaimer limiting claimed beneficial ownership to pecuniary interest.

Positive

• Discloses a material stake of 7,431,147 shares (5.8%), improving market transparency about significant holders
• Filing states holdings are held in the ordinary course for advisory clients and were not acquired to influence control

Negative

• No sole voting or dispositive power reported, indicating the reporting persons do not exercise individual control
• Reporting persons disclaim beneficial ownership except to the extent of pecuniary interest, which limits clarity on direct influence

Insights

Securities Analyst

TL;DR: A disclosed 5.8% beneficial stake is material in size but the filing affirms a passive, advisory-client ownership structure.

The filing reports 7,431,147 shares (5.8% of the class) held by related reporting persons with shared voting power of 6,658,116 and shared dispositive power of 7,431,147. It expressly states the shares are held for advisory clients and were not acquired to influence control, consistent with a Schedule 13G passive disclosure. For investors this documents a meaningful position size without an asserted intent to pursue control actions. The report also includes a disclaimer limiting beneficial ownership claims to pecuniary interest, which affects interpretations of direct influence.

Corporate Governance Expert

TL;DR: The disclosure signals concentrated ownership among advisory clients but explicitly disclaims control intent and sole voting authority.

The filing identifies three related reporting persons sharing voting and dispositive authority rather than holding sole powers. The explicit statement that holdings are held in the ordinary course for advisory clients and not for changing control is central to governance assessment: it reduces immediate concerns about activist engagement or control contests. The disclaimer of beneficial ownership except for pecuniary interest further clarifies the reporting persons' stated legal posture regarding control and Section 16 implications.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

NEOGENOMICS, INC.

(Name of Issuer)

Common stock ($0.001 par value)

(Title of Class of Securities)

64049M209

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 64049M209

1

Names of Reporting Persons

Greenhouse Funds LLLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,658,116.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,431,147.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,431,147.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 64049M209

1

Names of Reporting Persons

Greenhouse GP LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,658,116.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,431,147.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,431,147.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

HC, OO

SCHEDULE 13G

CUSIP No. 64049M209

1

Names of Reporting Persons

Joseph Milano

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 6,658,116.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,431,147.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,431,147.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: NEOGENOMICS, INC.
(b)	Address of issuer's principal executive offices: 9490 NeoGenomics Way, Fort Myers, Florida 33912
Item 2.
(a)	Name of person filing: Greenhouse Funds LLLP Greenhouse GP LLC Joseph Milano
(b)	Address or principal business office or, if none, residence: Greenhouse Funds LLLP 605 S. Eden St. Suite 250 Baltimore, MD 21231 Greenhouse GP LLC 605 S. Eden St. Suite 250 Baltimore, MD 21231 Joseph Milano 605 S. Eden St. Suite 250 Baltimore, MD 21231
(c)	Citizenship: Greenhouse Funds LLLP - Delaware Greenhouse GP LLC - Delaware Joseph Milano - United States
(d)	Title of class of securities: Common stock ($0.001 par value)
(e)	CUSIP No.: 64049M209
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Greenhouse Funds LLLP - 7,431,147 Greenhouse GP LLC - 7,431,147 Joseph Milano - 7,431,147
(b)	Percent of class: Greenhouse Funds LLLP - 5.8% Greenhouse GP LLC - 5.8% Joseph Milano - 5.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Greenhouse Funds LLLP - 0 Greenhouse GP LLC - 0 Joseph Milano - 0
	(ii) Shared power to vote or to direct the vote: Greenhouse Funds LLLP - 6,658,116 Greenhouse GP LLC - 6,658,116 Joseph Milano - 6,658,116
	(iii) Sole power to dispose or to direct the disposition of: Greenhouse Funds LLLP - 0 Greenhouse GP LLC - 0 Joseph Milano - 0
	(iv) Shared power to dispose or to direct the disposition of: Greenhouse Funds LLLP - 7,431,147 Greenhouse GP LLC - 7,431,147 Joseph Milano - 7,431,147
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All of the securities reported in this Schedule 13G are directly owned by advisory clients of Greenhouse Funds, LLLP. None of those advisory clients may be deemed to beneficially own more than 5% of the Common stock ($0.001 par value).
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Greenhouse Funds LLLP

Signature:	By: /s/ Joseph Milano*
Name/Title:	Joseph Milano / Authorized Person of the general partner
Date:	08/13/2025

Greenhouse GP LLC

Signature:	By: /s/ Joseph Milano*
Name/Title:	Joseph Milano / Authorized Person
Date:	08/13/2025

Joseph Milano

Signature:	By: /s/ Joseph Milano*
Name/Title:	Joseph Milano*
Date:	08/13/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

Who filed the Schedule 13G reporting a stake in NeoGenomics (NEO)?

Greenhouse Funds LLLP, Greenhouse GP LLC and Joseph Milano are the reporting persons listed in the filing.

How many NeoGenomics (NEO) shares are reported and what percentage do they represent?

7,431,147 shares are reported, representing 5.8% of the class according to the filing.

What voting and dispositive powers are reported for the NEO stake?

The reporting persons state 0 sole voting power, 6,658,116 shared voting power, 0 sole dispositive power, and 7,431,147 shared dispositive power.

Are the shares held for advisory clients or for the reporting persons directly?

The filing states the securities are directly owned by advisory clients of Greenhouse Funds LLLP and notes no advisory client is known to beneficially own more than 5%.

Does the filing indicate an intent to influence control of NeoGenomics?

No. The filing certifies the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Does the reporting person claim full beneficial ownership for Section 16 purposes?

No. Each reporting person includes a disclaimer that they disclaim beneficial ownership except to the extent of their pecuniary interest.